Arterys And Therapixel Team Up For AI-powered Breast Cancer Solution
Arterys, a Tempus company, has announced a US and EU distribution agreement with Therapixel, a medical imaging software company providing AI...
2 min read
Arterys
:
May 31, 2022
Earlier this month, the American College of Radiology's Society of Breast Imaging Symposium, SBI-ACR 2022, was held in Savannah, GA. The event was well attended, both in-person and online, and highlighted patient navigation in cancer care and new breast risk assessment technologies and health solutions.
We connected with many radiologists and guests at our booth during the four-day event at the Savannah Convention Center. Our community continues to share ways to improve accuracy, efficiency, and precision screenings at these events.
Patient navigation was a recurring topic at the event. This relatively new concept refers to the individualized care provided to cancer patients, families, and caregivers to ease multiple barriers and facilitate timely access to qualified medical and psychosocial care. Patient navigation has become a healthcare buzzword as organizations strive to increase program efficiencies and system retention rates. We expect to hear more about this in upcoming cancer health conferences.
As we announced in a recent press release and shared at SBI-ACR, we signed a global distribution agreement with iCAD, Inc. to launch a new Breast AI SaaS solution. This partnership expands access to iCAD's full suite of breast health solutions on Arterys' fully cloud-native platform.
The Arterys Breast AI solution offers:
You can learn more in the brief video below.
There was a lot of discussion on the current challenges impacting radiologist practices at SBI-ACR. Unsurprisingly, COVID-19's impact on budgets making it difficult for practices to take advantage of some of the new breast health care technologies, is one challenge.
Additionally, radiologist burnout and fatigue have been front and center this year, especially as breast centers move to digital tomosynthesis. From 4 images to over 200 has overwhelmed some radiologists.
In addressing these two specific challenges, we refer radiologists to how our Breast AI solution can help. Specifically:
We would love to provide you with a demo of Breast AI, giving you an overview of how it is an innovative solution for breast cancer detection, measuring breast density, and assessing personalized risk. The software offers clinically proven benefits to clinicians and patients. Schedule a demo today to learn more!
Arterys, a Tempus company, has announced a US and EU distribution agreement with Therapixel, a medical imaging software company providing AI...
The 2023 Society of Breast Imaging (SBI) Breast Imaging Symposium is a must-attend event for radiologists and healthcare professionals involved in...
There are a lot of radiology conferences and events in March, and you can connect with the Arterys team at a number of them! Six specific events in...